Approximately 43% of patients developed de novo diabetes following acute pancreatitis (AP). Among patients with de novo ...
Patients with obesity hospitalized with acute pancreatitis who receive GLP-1 RAs have a significantly lower mortality and complication rate at 6 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback